Prospective Cohort Study of Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma in 8510 Patients

Gastroenterology

Volumn 131, Issue 2, 2006, Pages 461-469

  Takayasu, Kenichi ^a   Arii, Shigeki ^b   Ikai, Iwao ^c   Omata, Masao ^d   Okita, Kiwamu ^e   Ichida, Takafumi ^f   Matsuyama, Yutaka ^g   Nakanuma, Yasuni ^h   Kojiro, Masamichi ⁱ   Makuuchi, Masatoshi ^j   Yamaoka, Yoshio ^k  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e Social Insurance Alliance Shimonoseki Kohsei Hospital   (Japan)

^f JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g UNIVERSITY OF TOKYO   (Japan)

^h KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

ⁱ KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^j GRADUATE SCHOOL OF MEDICINE   (Japan)

^k Kitano Hospital   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; GELATIN SPONGE; IODINATED POPPYSEED OIL;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; COHORT ANALYSIS; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; PORTAL VEIN; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; TUMOR VOLUME;

EID: 33746528885     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2006.05.021     Document Type: Article

References (54)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Estimating the world cancer burden. Globocan 2000. Int J Cancer 94 (2001) 153-156
2. Imamura H., Matsuyama Y., Tanaka E., Ohkubo T., Hasegawa K., Miyagawa S., Sugawara Y., Minagawa M., Takayama T., Kawasaki S., and Makuuchi M. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 38 (2003) 200-207
3. Chen M.F., Hwang T.L., Jeng L.B., Wang C.S., Jan Y.Y., and Chen S.C. Postoperative recurrence of hepatocellular carcinoma. Two hundred five consecutive patients who underwent hepatic resection in 15 years. Arch Surg 129 (1994) 738-742
4. Koda M., Murawaki Y., Mitsuda A., Ohyama K., Horie Y., Suou T., Kawasaki H., and Ikawa S. Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma. Cancer 88 (2000) 529-537
5. Arii S., Yamaoka Y., Futagawa S., Inoue K., Kobayashi K., Kojiro M., Makuuchi M., Nakamura Y., Okita K., Yamada R., and The Liver Cancer Study Group of Japan. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas. a retrospective and nationwide survey in Japan. Hepatology 32 (2000) 1224-1229
6. Lin D.Y., Liaw Y.F., Lee T.Y., and Lai C.M. Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma-a randomized controlled trial. Gastroenterology 94 (1988) 453-456
7. Pelletier G., Roche A., Ink O., Anciaux M.L., Derhy S., Rougier P., Lenoir C., Attali P., and Etienne J.P. A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J Hepatol 11 (1990) 181-184
8. GETCH. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 332 (1995) 1256-1261
9. Bruix J., Llovet J.M., Castells A., Montana X., Bru C., Ayuso M.C., Vilana R., and Rodes J. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma. results of a randomized, controlled trial in a single institution. Hepatology 27 (1998) 1578-1583
10. Pelletier G., Ducreux M., Gay F., Luboinski M., Hagege H., Dao T., Van Steenbergen W., Buffet C., Rougier P., Adler M., Pignon J.P., Roche A., and Group CHC. Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization. a multicenter randomized trial. J Hepatol 29 (1998) 129-134
11. Llovet J.M., Real M.I., Montana X., Planas R., Coll S., Aponte J., Ayuso C., Sala M., Muchart J., Sola R., Rodes J., and Bruix J. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma. a randomised controlled trial. Lancet 359 (2002) 1734-1739
12. Lo C.M., Ngan H., Tso W.K., Liu C.L., Lam C.M., Poon R.T., Fan S.T., and Wong J. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35 (2002) 1164-1171
13. Doyon D.M.A., Jourde A.M., Regensberg C., and Frileux C. L'embolisation arterielle hepatique dans les tumeurs malignes du foie. Ann Radiol 17 (1974) 593-603
14. Yamada R., Nakatsuka H., Nakamura K., Sato M., Tamaoka K., Takemoto K., Minakuchi K., Yamaguchi S., Tamaki M., Monna T., and Yamamoto S. Transcatheter arterial embolization therapy in unresectable hepatomas-experience in 15 cases. Acta Hepatologica Japonica 20 (1979) 595-603
15. Konno T., Maeda H., Iwai K., Tashiro S., Maki S., Morinaga T., Mochinaga M., Hiraoka T., and Yokoyama I. Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma. a preliminary report. Eur J Cancer Clin Oncol 19 (1983) 1053-1065
16. Ohishi H., Uchida H., Yoshimura H., Ohue S., Ueda J., Katsuragi M., Matsuo N., and Hosogi Y. Hepatocellular carcinoma detected by iodized oil. Use of anticancer agents. Radiology 154 (1985) 25-29
17. Yumoto Y., Jinno K., Tokuyama K., Araki Y., Ishimitsu T., Maeda H., Konno T., Iwamoto S., Ohnishi K., and Okuda K. Hepatocellular carcinoma detected by iodized oil. Radiology 154 (1985) 19-24
18. Takayasu K., Shima Y., Muramatsu Y., Moriyama N., Yamada T., Makuuchi M., Hasegawa H., and Hirohashi S. Hepatocellular carcinoma. treatment with intra-arterial iodized oil with and without chemotherapeutic agents. Radiology 163 (1987) 345-351
19. Sasaki Y., Imaoka S., Kasugai H., Fujita M., Kawamoto S., Ishiguro S., Kojima J., Ishikawa O., Ohigashi H., Furukawa H., et al. A new approach to chemoembolization therapy for hepatoma using ethiodized oil, cisplatin, and gelatin sponge. Cancer 60 (1987) 1194-1203
20. Kasugai H., Kojima J., Tatsuta M., Okuda S., Sasaki Y., Imaoka S., Fujita M., and Ishiguro S. Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiodized oil. Gastroenterology 97 (1989) 965-971
21. Nakamura H., Hashimoto T., Oi H., and Sawada S. Transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology 170 (1989) 783-786
22. Uchida H., Ohishi H., Matsuo N., Nishimine K., Ohue S., Nishimura Y., Maeda M., and Yoshioka T. Transcatheter hepatic segmental arterial embolization using lipiodol mixed with an anticancer drug and Gelfoam particles for hepatocellular carcinoma. Cardiovasc Intervent Radiol 13 (1990) 140-145
23. Matsui O., Kadoya M., Yoshikawa J., Gabata T., Arai K., Demachi H., Miyayama S., Takashima T., Unoura M., and Kogayashi K. Small hepatocellular carcinoma. treatment with subsegmental transcatheter arterial embolization. Radiology 188 (1993) 79-83
24. The Cooperative Study Group for Liver Cancer Treatment of Japan, Kawai S., Tani M., Okamura J., Ogawa M., Ohashi Y., Monden M., Hayashi S., Inoue J., Kawarada Y., Kusano M., Kubo Y., Kuroda C., Sakata Y., Shimamura Y., Jinno K., Takahashi A., Takayasu K., Tamura K., Nagasue N., Nakanishi Y., Makino M., Masuzawa M., Yumoto Y., Mori T., and Oda T. Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma-a comparison between L-TAE with farmorubicin and L-TAE with adriamycin. preliminary results (second cooperative study). Cancer Chemother Pharmacol 33 Suppl (1994) S97-S102
25. Chang J.M., Tzeng W.S., Pan H.B., Yang C.F., and Lai K.H. Transcatheter arterial embolization with or without cisplatin treatment of hepatocellular carcinoma. A randomized controlled study. Cancer 74 (1994) 2449-2453
26. Bronowicki J.P., Vetter D., Dumas F., Boudjema K., Bader R., Weiss A.M., Wenger J.J., Boissel P., Bigard M.A., and Doffoel M. Transcatheter oily chemoembolization for hepatocellular carcinoma. A 4-year study of 127 French patients. Cancer 74 (1994) 16-24
27. Stefanini G.F., Amorati P., Biselli M., Mucci F., Celi A., Arienti V., Roversi R., Rossi C., Re G., and Gasbarrini G. Efficacy of transarterial targeted treatments on survival of patients with hepatocellular carcinoma. An Italian experience. Cancer 75 (1995) 2427-2434
28. Hatanaka Y., Yamashita Y., Takahashi M., Koga Y., Saito R., Nakashima K., Urata J., and Miyao M. Unresectable hepatocellular carcinoma. analysis of prognostic factors in transcatheter management. Radiology 195 (1995) 747-752
29. Chung J.W., Park J.H., Han J.K., Choi B.I., Han M.C., Lee H.S., and Kim C.Y. Hepatic tumors. predisposing factors for complications of transcatheter oily chemoembolization. Radiology 198 (1996) 33-40
30. Solomon B., Soulen M.C., Baum R.A., Haskal Z.J., Shlansky-Goldberg R.D., and Cope C. Chemoembolization of hepatocellular carcinoma with cisplatin, doxorubicin, mitomycin-C, ethiodol, and polyvinyl alcohol. prospective evaluation of response and survival in a US population. J Vasc Interv Radiol 10 (1999) 793-798
31. Savastano S., Miotto D., Casarrubea G., Teso S., Chiesura-Corona M., and Feltrin G.P. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with Child's grade A or B cirrhosis. a multivariate analysis of prognostic factors. J Clin Gastroenterol 28 (1999) 334-340
32. Takayasu K., Muramatsu Y., Maeda T., Iwata R., Furukawa H., Moriyama N., Okusaka T., Okada S., and Ueno H. Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system. analysis of factors affecting local recurrence and survival rates. AJR Am J Roentgenol 176 (2001) 681-688
33. Ikai I., Arii S., Ichida T., Okita K., Omata M., Kojiro M., Takayasu K., Nakanuma Y., Makuuchi M., Matsuyama Y., and Yamaoka Y. Report of the 16th follow-up survey of primary liver cancer. Hepatol Res 32 (2005) 163-172
34. Araki T., Itai Y., Furui S., and Tasaka A. Dynamic CT densitometry of hepatic tumors. AJR Am J Roentgenol 135 (1980) 1037-1043
35. The Liver Cancer Study Group of Japan. The general rules for the clinical and pathological study of primary liver cancer. Version 4 (2000), Kanehara & Co., Ltd, Tokyo
36. The Liver Cancer Study Group of Japan. The general rules for the clinical and pathological study of primary liver cancer. Version 2 (2003), Kanehara & Co., Ltd, Tokyo
37. Makuuchi M., Belghiti J., Belli G., Fan S.T., Lau J.W., Ringe B., Strasberg S.M., Vauthey J.N., Yamaoka Y., and Yamasaki S. IHPBA concordant classification of primary liver cancer. working group report. J Hepatobiliary Pancreat Surg 10 (2003) 26-30
38. Yamada R., Kishi K., Sonomura T., Tsuda M., Nomura S., and Satoh M. Transcatheter arterial embolization in unresectable hepatocellular carcinoma. Cardiovasc Intervent Radiol 13 (1990) 135-139
39. Ikeda K., Kumada H., Saitoh S., Arase Y., and Chayama K. Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. An analysis by the Cox proportional hazard model. Cancer 68 (1991) 2150-2154
40. The Liver Cancer Study Group of Japan. Report of the 12th follow-up survey of primary liver cancer (1996), Shinkou-insatsu Press, Kyoto 100
41. Trevisani F., D'Intino P.E., Caraceni P., Pizzo M., Stefanini G.F., Mazziotti A., Grazi G.L., Gozzetti G., Gasbarrini G., and Bernardi M. Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patients. Cancer 75 (1995) 2220-2232
42. The Liver Cancer Study Group of Japan. Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. Cancer 74 (1994) 2772-2780
43. Vauthey J.N., Lauwers G.Y., Esnaola N.F., Do K.A., Belghiti J., Mirza N., Curley S.A., Ellis L.M., Regimbeau J.M., Rashid A., Cleary K.R., and Nagorney D.M. Simplified staging for hepatocellular carcinoma. J Clin Oncol 20 (2002) 1527-1536
44. Okuda K., Ohtsuki T., Obata H., Tomimatsu M., Okazaki N., Hasegawa H., Nakajima Y., and Ohnishi K. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 56 (1985) 918-928
45. Llovet J.M., Bru C., and Bruix J. Prognosis of hepatocellular carcinoma. the BCLC staging classification. Semin Liver Dis 19 (1999) 329-338
46. The Cancer of the Liver Italian Program (CLIP) Investigators. Prospective validation of the CLIP score. a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology 31 (2000) 840-845
47. Kudo M., Chung H., Haji S., Osaki Y., Oka H., Seki T., Kasugai H., Sasaki Y., and Matsunaga T. Validation of a new prognostic staging system for hepatocellular carcinoma. the JIS score compared with the CLIP score. Hepatology 40 (2004) 1396-1405
48. Nanashima A., Sumida Y., Morino S., Yamaguchi H., Tanaka K., Shibasaki S., Ide N., Sawai T., Yasutake T., Nakagoe T., and Nagayasu T. The Japanese integrated staging score using liver damage grade for hepatocellular carcinoma in patients after hepatectomy. Eur J Surg Oncol 30 (2004) 765-770
49. Ernst O., Sergent G., Mizrahi D., Delemazure O., Paris J.C., and L'Hermine C. Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization. comparison of planned periodic chemoembolization and chemoembolization based on tumor response. AJR Am J Roentgenol 172 (1999) 59-64
50. Vetter D., Wenger J.J., Bergier J.M., Doffoel M., and Bockel R. Transcatheter oily chemoembolization in the management of advanced hepatocellular carcinoma in cirrhosis. results of a Western comparative study in 60 patients. Hepatology 13 (1991) 427-433
51. Nakao N., Kotake M., Miura K., Ohnishi M., and Miura T. Rupture of hepatocellular carcinoma following transcatheter arterial embolization. Radiat Med 6 (1988) 147-149
52. Kawai S., Tani M., Okamura J., Ogawa M., Ohashi Y., Monden M., Hayashi S., Inoue J., Kawarada Y., Kusano M., Kubo Y., Kuroda C., Sakata Y., Shimamura Y., Jinno K., Takahashi A., Takayasu K., Tamura K., Nagasue N., Nakanishi Y., Makino M., Masuzawa M., Yumoto Y., Mori T., Oda T., and The Cooperative Study Group for Liver Cancer Treatment of Japan. Prospective and randomized trial of lipiodol-transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma. a comparison of epirubicin and doxorubicin (second cooperative study). Semin Oncol 24 (1997) S6-S45
53. Sato M., Yamada R., Uchida B., Hedgepeth P., and Rosch J. Effects of hepatic artery embolization with Lipiodol and gelatin sponge particles on normal swine liver. Cardiovasc Intervent Radiol 16 (1993) 348-354
54. Kan Z., and Wallace S. Sinusoidal embolization. impact of iodized oil on hepatic microcirculation. J Vasc Interv Radiol 5 (1994) 881-886